Praxis Precision Medicines Inc.

Epilepsy and Seizure Disorders

Clinical research focuses on adult epilepsy, including focal epilepsy and primary generalized tonic-clonic seizures, with attention to seizure control and treatment response in people using background anti-seizure medications.

  • Focal onset seizures
  • Primary generalized tonic-clonic seizures
  • Seizure frequency

The sponsor also studies photoparoxysmal electroencephalogram response in epilepsy, reflecting interest in seizure-related neurophysiological markers.

Developmental and Epileptic Encephalopathies

Research extends to severe pediatric developmental and epileptic encephalopathies, with a particular focus on SCN2A and SCN8A-related disease.

  • SCN2A-DEE
  • SCN8A-DEE
  • Early-onset epileptic syndromes

These studies address countable motor seizures and broader seizure burden in children with genetically defined epileptic disorders.

The sponsor has a clear therapeutic interest in voltage-gated sodium channel biology, especially conditions linked to SCN2A and SCN8A dysfunction.

  • SCN2A developmental and epileptic encephalopathy
  • Sodium channel dysfunction
  • Neurogenetic epilepsy

This area includes research in both adult and pediatric populations with inherited seizure disorders.

Therapeutic Development in Seizure Control

Current trials explore investigational treatments for focal seizures, focal onset seizures, and tonic-clonic seizures, alongside treatment assessment in participants receiving existing anti-seizure therapy.

  • Adjunctive seizure treatment
  • Adult seizure management
  • Pediatric seizure disorders

Research activity also includes evaluation of drug-drug interaction potential in support of neurological treatment development.

Want to learn more about this study or check if you can participate? Contact us.

Matched clinical trials

  • Study of PRAX-628 to evaluate safety and effectiveness in adults with epilepsy who have focal seizures or generalized tonic-clonic seizures

    Recruiting

    3 1 1
    Investigated drugs:
    Germany Italy Poland Spain
  • A study to evaluate the effectiveness and safety of vormatrigine in adults with focal epilepsy who are taking one to three anti-seizure medications.

    Not yet recruiting

    3 1
    Investigated drugs:
    Czechia Germany Italy Poland Spain
  • Study of Elsunersen in Children with SCN2A Developmental and Epileptic Encephalopathy to Reduce Seizures

    Not yet recruiting

    3 1 1
    Investigated diseases:
    Germany Italy
  • Study on PRAX-628 for Adults with Focal Onset or Generalized Tonic-Clonic Seizures

    Not recruiting

    2 1 1
    Investigated drugs:
    Germany Spain
  • Study on PRAX-562 for Children with Developmental and Epileptic Encephalopathies

    Not recruiting

    2 1
    Investigated diseases:
    Spain
  • Study on PRAX-628 for Epilepsy Patients with Light-Induced EEG Response

    Not recruiting

    2 1
    Investigated diseases:
    Investigated drugs:
    The Netherlands